Oppenheimer & Co. Inc. Sells 1,746 Shares of SPDR S&P Biotech Etf


Oppenheimer & Co. Inc. lowered its position in SPDR S&P Biotech ETF by 2.5% in the 3rd quarter, according to the company in its most recent filing with the SEC.



from Biotech News